70 related articles for article (PubMed ID: 7742601)
21. Availability of conjugated ganglioside GD2 monoclonal antibody.
Warzynski MJ; Roys JL; Peterson JW; DeLa Vega H
Cytometry B Clin Cytom; 2005 May; 65(1):42-3. PubMed ID: 15806571
[No Abstract] [Full Text] [Related]
22. Antibody response to murine anti-GD2 monoclonal antibodies: correlation with patient survival.
Cheung NK; Cheung IY; Canete A; Yeh SJ; Kushner B; Bonilla MA; Heller G; Larson SM
Cancer Res; 1994 Apr; 54(8):2228-33. PubMed ID: 8174131
[TBL] [Abstract][Full Text] [Related]
23. DNA vaccine expressing the mimotope of GD2 ganglioside induces protective GD2 cross-reactive antibody responses.
Bolesta E; Kowalczyk A; Wierzbicki A; Rotkiewicz P; Bambach B; Tsao CY; Horwacik I; Kolinski A; Rokita H; Brecher M; Wang X; Ferrone S; Kozbor D
Cancer Res; 2005 Apr; 65(8):3410-8. PubMed ID: 15833876
[TBL] [Abstract][Full Text] [Related]
24. Cytotoxicity of L-cycloserine against human neuroblastoma and medulloblastoma cells is associated with the suppression of ganglioside expression.
Cinatl J; Cinatl J; Kotchetkov R; Pouckova P; Vogel JU; Rabenau H; Michaelis M; Kornhuber B
Anticancer Res; 1999; 19(6B):5349-54. PubMed ID: 10697560
[TBL] [Abstract][Full Text] [Related]
25. Radioimmunodetection of neuroblastoma with antineuroblastoma monoclonal antibody.
Etoh T; Takahashi H; Ohnuma N; Maie M; Tanabe M; Kuriyama Y
Med Pediatr Oncol; 1987; 15(4):178-80. PubMed ID: 3657704
[TBL] [Abstract][Full Text] [Related]
26. Human monoclonal antibody to tumor-associated ganglioside GD2.
Katano M; Saxton RE; Irie RF
J Clin Lab Immunol; 1984 Nov; 15(3):119-26. PubMed ID: 6099419
[TBL] [Abstract][Full Text] [Related]
27. Induction of Ab3 and Ab3' antibody was associated with long-term survival after anti-G(D2) antibody therapy of stage 4 neuroblastoma.
Cheung NK; Guo HF; Heller G; Cheung IY
Clin Cancer Res; 2000 Jul; 6(7):2653-60. PubMed ID: 10914706
[TBL] [Abstract][Full Text] [Related]
28. Tumor imaging by antineuroblastoma monoclonal antibody and its application to treatment.
Etoh T; Takahashi H; Maie M; Ohnuma N; Tanabe M
Cancer; 1988 Oct; 62(7):1282-6. PubMed ID: 3416269
[TBL] [Abstract][Full Text] [Related]
29. Distribution of disialoganglioside GD2-antigen and binding of anti-GD2 antibodies on spheroids of neuroblastoma cell line.
Heiss P; Bermatz S; Wehnes H; Heinzmann U; Senekowitsch-Schmidtke R
Anticancer Res; 1997; 17(4B):3145-7. PubMed ID: 9329622
[TBL] [Abstract][Full Text] [Related]
30. New method for quantitative analysis of GD2 ganglioside in plasma of neuroblastoma patients.
Czaplicki D; Horwacik I; Kowalczyk A; Wieczorek A; Bolek-Marzec K; Balwierz W; Kozik A; Rokita H
Acta Biochim Pol; 2009; 56(3):423-31. PubMed ID: 19724779
[TBL] [Abstract][Full Text] [Related]
31. Anti-neuroblastoma effect of ch14.18 antibody produced in CHO cells is mediated by NK-cells in mice.
Zeng Y; Fest S; Kunert R; Katinger H; Pistoia V; Michon J; Lewis G; Ladenstein R; Lode HN
Mol Immunol; 2005 Jul; 42(11):1311-9. PubMed ID: 15950727
[TBL] [Abstract][Full Text] [Related]
32. Immunolocalization of neuroblastoma using radiolabeled monoclonal antibody UJ13A.
Goldman A; Vivian G; Gordon I; Pritchard J; Kemshead J
J Pediatr; 1984 Aug; 105(2):252-6. PubMed ID: 6747756
[TBL] [Abstract][Full Text] [Related]
33. Effect of a chimeric anti-ganglioside GD2 antibody on cell-mediated lysis of human neuroblastoma cells.
Barker E; Mueller BM; Handgretinger R; Herter M; Yu AL; Reisfeld RA
Cancer Res; 1991 Jan; 51(1):144-9. PubMed ID: 1988079
[TBL] [Abstract][Full Text] [Related]
34. Structural characterization and in vivo immunosuppressive activity of neuroblastoma GD2.
Li R; Gage D; McKallip R; Ladisch S
Glycoconj J; 1996 Jun; 13(3):385-9. PubMed ID: 8781969
[TBL] [Abstract][Full Text] [Related]
35. Iodine 131 labeled GD2 monoclonal antibody in the diagnosis and therapy of human neuroblastoma.
Cheung NK; Miraldi FD
Prog Clin Biol Res; 1988; 271():595-604. PubMed ID: 3406022
[No Abstract] [Full Text] [Related]
36. Antidisialoganglioside ricin A-chain immunotoxins show potent antitumor effects in vitro and in a disseminated human neuroblastoma severe combined immunodeficiency mouse model.
Gottstein C; Schön G; Tawadros S; Kube D; Wargalla-Plate UC; Hansmann ML; Wacker HH; Berthold F; Diehl V; Engert A
Cancer Res; 1994 Dec; 54(23):6186-93. PubMed ID: 7954465
[TBL] [Abstract][Full Text] [Related]
37. Application of the murine anti-Gd-2 antibody 14.Gd-2a for diagnosis and therapy of neuroblastoma.
Reuland P; Handgretinger R; Smykowsky H; Dopfer R; Klingebiel T; Miller BM; Reisfeld RA; Gallagher S; Koscelniak E; Treuner J
Int J Rad Appl Instrum B; 1991; 18(1):121-5. PubMed ID: 2010296
[TBL] [Abstract][Full Text] [Related]
38. Immunoscintigraphy of human mammary carcinoma xenografts using monoclonal antibodies 12H12 and BM-2 labeled with 99mTc and radioiodine.
Brümmendorf TH; Kaul S; Schuhmacher J; Baum RP; Matys R; Klivényi G; Adams S; Bastert G
Cancer Res; 1994 Aug; 54(15):4162-8. PubMed ID: 8033148
[TBL] [Abstract][Full Text] [Related]
39. Human IgM monoclonal anti-GD2 antibody: reactivity to a human melanoma xenograft.
Katano M; Saxton RE; Tsuchida T; Irie RF
Jpn J Cancer Res; 1986 Jun; 77(6):584-94. PubMed ID: 3089993
[TBL] [Abstract][Full Text] [Related]
40. Isolation and structural analysis of peptide mimotopes for the disialoganglioside GD2, a neuroblastoma tumor antigen.
Förster-Waldl E; Riemer AB; Dehof AK; Neumann D; Brämswig K; Boltz-Nitulescu G; Pehamberger H; Zielinski CC; Scheiner O; Pollak A; Lode H; Jensen-Jarolim E
Mol Immunol; 2005 Feb; 42(3):319-25. PubMed ID: 15589320
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
